News for Healthier Living

New Treatment Combination Delays Multiple Myeloma Progression and May Improve Survival, Study Finds

Patients with relapsed multiple myeloma lived significantly longer without disease progression and showed early survival gains in a global phase 3 trial of a talquetamab-based immunotherapy combo, offering new hope for improved treatment outcomes.

June 15, 2026


June 15 2026

June 14 2026

June 13 2026

June 12 2026

June 11 2026

June 10 2026

June 9 2026

June 8 2026

June 7 2026

June 5 2026

June 4 2026

June 3 2026

June 2 2026

June 1 2026